Endocrinologist News and Research

RSS

ADA Maryland Chapter, WellDoc collaborate to empower patients with type 2 diabetes

The American Diabetes Association (ADA) Maryland Chapter and WellDoc®, a health care behavioral science and technology company, have announced the launch of a collaboration to empower people in Maryland with type 2 diabetes to take control of their diabetes by improving their day-to-day self-management.

16 Sep 2014

Viewpoints: Ebola takes us to 'uncharted waters'; the failure of workplace 'wellness' programs

There have been more than 4,300 cases and 2,300 deaths over the past six months. Last week, the World Health Organization warned that, by early October, there may be thousands of new cases per week in Liberia, Sierra Leone, Guinea and Nigeria. What is not getting said publicly, despite briefings and discussions in the inner circles of the world's public health agencies, is that we are in totally uncharted waters and that Mother Nature is the only force in charge of the crisis at this time (Michael T. Osterholm, 9/11).

15 Sep 2014

Gut hormone-drug combination therapy more effective at improving type 2 diabetes

Combined treatment with a drug that mimics the action of a gut hormone and basal insulin is more effective at improving blood sugar control than other anti-diabetic treatments, with similar rates of hypoglycaemia (dangerously low blood sugar levels) and greater weight loss, a systematic review and meta-analysis published in The Lancet shows.

15 Sep 2014

Using a nanotech microchip to diagnose type 1 diabetes: an interview with Dr. Brian Feldman, Stanford School of Medicine

The most common form of diabetes is sometimes referred to as metabolic diabetes, which is the diabetes most people are very familiar with, type 2 diabetes. This form of diabetes is most prevalent in people that are overweight or obese. Historically, it has been confined to adults or older patients but it has been on the rise as the global obesity problem has continued to worsen.

20 Aug 2014

Eating pistachios may reduce body's response to stresses among adults with diabetes

Among people with type 2 diabetes, eating pistachios may reduce the body's response to the stresses of everyday life, according to Penn State researchers.

6 Aug 2014

Research roundup: The effect of expensive cancer therapies; missed hospital handovers; children's mental health needs

Medicare uses more than a dozen different payment systems to set payment rates for the medical items and services the program covers for beneficiaries.

4 Aug 2014

GSK announces availability of once-weekly Tanzeum in pharmacies throughout the U.S.

GSK today announced that once-weekly Tanzeum (albiglutide), a prescription injectable treatment for type 2 diabetes in adults, as an adjunct to diet and exercise, is now available in pharmacies throughout the U.S.

29 Jul 2014

Portable, microchip-based test for diagnosing type-1 diabetes

An inexpensive, portable, microchip-based test for diagnosing type-1 diabetes could improve patient care worldwide and help researchers better understand the disease, according to the device's inventors at the Stanford University School of Medicine.

14 Jul 2014

Global toolkit for managing menopause

Created at Monash University, the world's first toolkit is designed for GPs to use with women from the age of 40. Thought to be the first of its kind, researchers say the toolkit has the potential to help manage menopausal conditions for women globally.

7 Jul 2014

Patients with Cushing’s syndrome experience significant weight loss while taking oral medication

Sinai Hospital of Baltimore endocrinologist, Henry G. Fein, M.D., today presented new research showing that patients with Cushing's syndrome, a rare disease that can lead to extreme weight gain, type 2 diabetes, high blood pressure and psychological issues, experienced significant, sustained weight loss while taking oral medication daily over a number of years to manage symptoms of the disease.

25 Jun 2014

RYGB surgery can help reduce heart disease risk in obese patients with Type 2 diabetes

Obese patients with Type 2 diabetes who don't have excessive surgical risk may find that Roux-en-Y gastric bypass (RYGB) surgery can help them reduce their risk of heart disease, a new clinical trial shows.

24 Jun 2014

Engaging in physical activity before attempting weight loss helps protect MetS patients from muscle loss

Younger and older women tend to lose lean muscle mass, along with fat, unless they engage in physical activity before they attempt weight loss, a new study from Israel finds. The results were presented Sunday at the joint meeting of the International Society of Endocrinology and the Endocrine Society: ICE/ENDO 2014 in Chicago.

24 Jun 2014

Improved physical fitness reduces risk of CKD in patients with Type 2 diabetes

Adults with Type 2 diabetes who improve their physical fitness lower their chances of getting chronic kidney disease (CKD), and if they already have kidney damage, they can improve their kidney function.

24 Jun 2014

Patients continue to lose bone at least 2 years after bariatric surgery, shows study

A new study shows that for at least two years after bariatric surgery, patients continue to lose bone, even after their weight stabilizes.

24 Jun 2014

Adults with Type 2 diabetes achieve better blood glucose control after sleeve gastrectomy surgery

Adults with Type 2 diabetes achieve better blood glucose (sugar) control two years after undergoing laparoscopic sleeve gastrectomy than do patients who receive standard medical diabetes care without this weight loss surgery, a new study finds.

23 Jun 2014

Soy protein supplements do not reduce testosterone levels in men with Type 2 diabetes

Soy protein supplements, which contain natural estrogens, do not reduce testosterone levels in men with Type 2 diabetes who already have borderline-low testosterone, according to a new study.

23 Jun 2014

Auxogyn receives clearance from FDA for Eeva System

Auxogyn, Inc. a leader in women's reproductive health, today announced that its first product, the Eeva System, received clearance from the U.S. Food and Drug Administration through its de novo classification process, a regulatory pathway for select novel, low- to moderate-risk medical devices that are first-of-a-kind.

10 Jun 2014

Endocrinologist News and Research

ADA Maryland Chapter, WellDoc collaborate to empower patients with type 2 diabetes

Viewpoints: Ebola takes us to 'uncharted waters'; the failure of workplace 'wellness' programs

Gut hormone-drug combination therapy more effective at improving type 2 diabetes

Using a nanotech microchip to diagnose type 1 diabetes: an interview with Dr. Brian Feldman, Stanford School of Medicine

Eating pistachios may reduce body's response to stresses among adults with diabetes

Research roundup: The effect of expensive cancer therapies; missed hospital handovers; children's mental health needs

GSK announces availability of once-weekly Tanzeum in pharmacies throughout the U.S.

Portable, microchip-based test for diagnosing type-1 diabetes

Global toolkit for managing menopause

Patients with Cushing’s syndrome experience significant weight loss while taking oral medication

RYGB surgery can help reduce heart disease risk in obese patients with Type 2 diabetes

Engaging in physical activity before attempting weight loss helps protect MetS patients from muscle loss

Improved physical fitness reduces risk of CKD in patients with Type 2 diabetes

Patients continue to lose bone at least 2 years after bariatric surgery, shows study

Adults with Type 2 diabetes achieve better blood glucose control after sleeve gastrectomy surgery

Soy protein supplements do not reduce testosterone levels in men with Type 2 diabetes

Auxogyn receives clearance from FDA for Eeva System

Studies stress the importance of vitamin D intake during first year of life

Experts from ProfNet network available to discuss timely issues in coverage area

Parathyroid hormone with vitamin D may be needed to assess impact on sugar metabolism

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News